- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04339959
Remote Assessment of Physical Function
May 6, 2024 updated by: University of New Mexico
Remote Assessment of Physical Function in Older Cancer Survivors
The primary objective is to evaluate the validity and reliability of using videoconferencing to assess physical performance tests self-administered by older cancer survivors in their own homes.
This remote assessment will be compared to the traditional face-to-face (i.e., in-person) assessment and to accelerometer data.
Study Overview
Status
Completed
Conditions
Detailed Description
The ultimate goal of this research study is to develop a test protocol to allow older cancer survivors to self-administer physical performance tests in the survivor's own home, while an investigator remotely assesses the tests via videoconferencing.
The test protocol includes written and video instructions and the test kit.
To achieve this objective, the study will proceed with a series of phases.
A similar concept of "saturation" will be applied, as is done in qualitative studies.
In qualitative studies, the number of focus groups or interviews is based on the saturation point, i.e., the point at which no new information is learned.
For the current study, each study phase will include a range in the number of participants enrolled.
At the point at which no new information is being learned, i.e., no further adjustments are needed to the test protocol, the study will proceed to the next phase.
Study Type
Observational
Enrollment (Actual)
33
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87131
- University of New Mexico
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Older cancer survivors
Description
Inclusion Criteria:
- Residence in New Mexico
- Previous diagnosis of cancer, completed primary treatment (surgery, radiation, chemotherapy), and not currently being treated for a recurrence.
- Mild-to-moderate physical functional impairment (≥2 functions limited a lot or limited a little on the Short Form 36-item Physical Function Subscale)
- Able to speak, read, & understand English
- Participating in less than 120 minutes per week of moderate-to-vigorous intensity physical activity
- Living independently and capable of walking 3 blocks without stopping to rest.
- Availability of a family member or friend to be present (for safety) during remote assessment of performance tests (Phases III and IV only)
- No severe impairments or pre-existing medical limitations for engaging in daily light-intensity physical activity (e.g., severe orthopedic conditions, pending hip/knee replacement, chronic vertigo, dementia)
- No severe hearing or vision deficits that would inhibit communication with the research team via videoconferencing and tablet use.
- Willing to use a tablet computer and videoconferencing software to communicate with a study team member during the assessment.
- Enough space (14 feet by 3 feet) to safely conduct the physical function tests.
- Not at high risk for falls
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Phase I
First, we will test proof-of-concept that participants will be able to follow the testing protocol and use the tablet computer to communicate with the investigator (10-12 participants).
The test protocol will be refined based on what is learned after a minimum of 10 participants.
We anticipate no more than 12 participants needed for this phase.
|
An android tablet with Wi-Fi and cellular will be used to compare videoconferencing with face-to-face assessment of 2 timed, physical performance tests.
The physical performance tests include the 30-second chair stand test (30s-CST) and the Timed Up & Go (TUG) test.
The TUG test is measured as the time to stand from a standard arm chair, walk 10 feet, turn around, return to start and sit down.
The 30s-CST is measured as the number of times a person comes to a full standing position from a chair in 30 seconds, as quickly as possible, without using ones' hands.
|
|
Phase II
Next, 10-20 new participants will be enrolled to evaluate the validity of videoconference vs. face-to-face assessment (i.e., direct observation) of physical performance.
Communication will occur between the remote assessor and the participant.
The direct observer will not communicate directly to the participant, unless there is a safety issue.
After completing 10 participants without a major change in the test protocol, we will proceed to the next phase.
|
An android tablet with Wi-Fi and cellular will be used to compare videoconferencing with face-to-face assessment of 2 timed, physical performance tests.
The physical performance tests include the 30-second chair stand test (30s-CST) and the Timed Up & Go (TUG) test.
The TUG test is measured as the time to stand from a standard arm chair, walk 10 feet, turn around, return to start and sit down.
The 30s-CST is measured as the number of times a person comes to a full standing position from a chair in 30 seconds, as quickly as possible, without using ones' hands.
|
|
Phase III
This phase involves participants repeating the test protocol, but without the face-to-face assessment (i.e., direct observation).
This will test the ability of the participant to receive the box of test instructions and materials in the mail, unpack the box, communicate with the remote assessor via videoconferencing, pack up the box, and return it (postage paid) to the study team.
This step will involve 5-10 participants from Phases 1 and 2, who have provided approval for future contact (see approved Future Contact form).
Once 5 participants have successfully and safely completed the test protocol, we will proceed to Phase 4.
|
An android tablet with Wi-Fi and cellular will be mailed to study participants to remotely assess 2 timed, physical performance tests.
The physical performance tests include the 30-second chair stand test (30s-CST) and the Timed Up & Go (TUG) test.
The TUG test is measured as the time to stand from a standard arm chair, walk 10 feet, turn around, return to start and sit down.
The 30s-CST is measured as the number of times a person comes to a full standing position from a chair in 30 seconds, as quickly as possible, without using ones' hands.
|
|
Phase IV
This phase is the same as Phase 3, except it includes newly enrolled participants, i.e., representing the first-time participants have enrolled/participated in this study.
This will eliminate the practice effect that will occur in phase 3.
This step will enroll 5-10 participants.
|
An android tablet with Wi-Fi and cellular will be mailed to study participants to remotely assess 2 timed, physical performance tests.
The physical performance tests include the 30-second chair stand test (30s-CST) and the Timed Up & Go (TUG) test.
The TUG test is measured as the time to stand from a standard arm chair, walk 10 feet, turn around, return to start and sit down.
The 30s-CST is measured as the number of times a person comes to a full standing position from a chair in 30 seconds, as quickly as possible, without using ones' hands.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Validation - 30-second Chair Stand Test
Time Frame: 1 day
|
Comparison of remote assessment to the traditional face-to-face (i.e., in-person; direct observer) assessment.
Phase 2 will enroll 10-20 participants, depending on the point at which no new information is learned about the use of the toolkit (including instructions).
Comparisons will be made between the direct observer and the remote assessor.
The 30-second chair stand test involves standing up from a chair and sitting down as quickly and safely as possible, preferably without the use of upper extremity support.
It is measured by the number of times a person comes to a full standing position from a chair in 30 seconds.
The outcome is the difference in the number of chair stands counted between the direct observer and the remote assessor.
|
1 day
|
|
Validation - Timed Up & Go Test
Time Frame: 1 day
|
Comparison of remote assessment to the traditional face-to-face (i.e., in-person; direct observer) assessment.
Phase 2 will enroll 10-20 participants, depending on the point at which no new information is learned about the use of the toolkit (including instructions).
The Timed Up & Go test involves standing up from a standard armchair, walking 10 feet, turning around (180° turn), and walking back to the chair and sitting down.
Comparisons will be made between the direct observer and the remote assessor.
The outcome is the difference in the number of seconds counted between the direct observer and the remote assessor.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reliability - Percentage of Participants Who Successfully Completed the Revised Protocol.
Time Frame: 3 months
|
Test of whether a sample of participants from Phases I & II can repeat the test protocol 2-3 months later.
This phase will enroll 5-10 participants.
The outcome is subjective -- whether the participant could successfully receive the test kit, follow the instructions, communicate with the remote assessor, and perform the two measure of physical performance.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Cindy K Blair, PhD, University of New Mexico
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 20, 2019
Primary Completion (Actual)
November 13, 2021
Study Completion (Actual)
November 13, 2021
Study Registration Dates
First Submitted
April 1, 2020
First Submitted That Met QC Criteria
April 6, 2020
First Posted (Actual)
April 9, 2020
Study Record Updates
Last Update Posted (Actual)
May 24, 2024
Last Update Submitted That Met QC Criteria
May 6, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- UNM HSC IRB 17-334
- K07CA215937-02 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer Survivors
-
Memorial Sloan Kettering Cancer CenterCompletedAdolescent Cancer Survivors | Pediatric Cancer SurvivorsUnited States
-
Thaddeus PaceCompletedCancer Survivors | Informal Cancer Caregivers (Family and Friends of Cancer Survivors)United States
-
The First Affiliated Hospital of Soochow UniversityRecruitingSurvivors of Young Male Cancer SurvivorsChina
-
Memorial Sloan Kettering Cancer CenterCompletedCancer Survivors | Statin Use Among High Risk SurvivorsUnited States
-
Azienda USL Reggio Emilia - IRCCSAmsterdam University Medical Centers (UMC), Location Academic Medical Center...Recruiting
-
Azienda Unita Sanitaria Locale Reggio EmiliaCompleted
-
Virginia Commonwealth UniversityCompleted
-
University of CalgaryCompleted
-
Centre Hospitalier Universitaire de NiceRecruiting
Clinical Trials on Remote Assessment of Physical Function with Direct Observation
-
Cedars-Sinai Medical CenterRecruitingNeoplasms | Chronic DiseaseUnited States
-
Johannes Gutenberg University MainzRecruiting
-
University of Wisconsin, MadisonCompletedBreast CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMalignant Primary Pelvic NeoplasmUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedHematopoietic and Lymphoid Cell Neoplasm | Lung Non-Small Cell CarcinomaUnited States
-
Abant Izzet Baysal UniversityRecruitingDiplegic Cerebral PalsyTurkey
-
Australian and New Zealand Intensive Care Research...Monash University; Monash HealthActive, not recruiting
-
Ohio State University Comprehensive Cancer CenterNational Institute on Aging (NIA)CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC... and other conditionsUnited States
-
University of ZurichETH ZurichRecruitingHemophilia B | Musculoskeletal Complication | Measurement Error | Hemophilia aSwitzerland